PAVmed retains significant influence over Lucid Diagnostics, with approximately 15% common equity interest and 25% voting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results